Bioaffinity technologies, inc.BIAFW.US Overview
US StockHealthcare
(No presentation for BIAFW)
BIAFW Overall Performance
BIAFW AI Analysis & Strategy
BIAFW Recent Performance
-
Bioaffinity technologies, inc.
0.81%
Avg of Sector
-1.14%
S&P500
BIAFW PowerScanner
BIAFW Key Information
BIAFW Valuation Metrics
BIAFW Earnings Table
BIAFW Profile
bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.